Molecular profiles of genomically high risk ER+ HER2- breast cancer tumors classified as functionally basal or luminal B by the 80-gene signature.

Authors

Joyce O'Shaughnessy

Joyce O'Shaughnessy

Texas Oncology-Baylor Sammons Cancer Center, US Oncology, Dallas, TX

Joyce O'Shaughnessy , Virginia G. Kaklamani , Yuan Yuan , Julie Barone , Sami Diab , Jennifer A. Crozier , Pat W. Whitworth , Karen L. Tedesco , Robert Maganini , Rakhshanda Layeequr Rahman , Carlos A. Encarnacion , Josien Haan , Amy Michelle Truitt , Andrea Menicucci , William Audeh

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Local/Regional/Adjuvant

Track

Breast Cancer

Sub Track

Biologic Correlates

Clinical Trial Registration Number

NCT03053193

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 563)

DOI

10.1200/JCO.2021.39.15_suppl.563

Abstract #

563

Poster Bd #

Online Only

Abstract Disclosures